HealthWise at 5 From 4.5 - KCBD NewsChannel 11 Lubbock


HealthWise at 5 From 4.5

  • Hip Fracture Drug

More than 350,000 people in the U.S. will fracture a hip this year and face surgery. Unfortunately, they'll also face an increased risk of blood clots following the surgery. The good news? The FDA has just approved a new treatment to help prevent this potentially fatal complication. Arixtra is the first and only drug in the US indicated for the prevention of blood clots after hip surgery. It's among a new class of anti-clotting medications recently granted priority FDA review. It's also the most extensively studied drug of its kind with more than 7,000 patients involved in clinical trials.

  • Lingering Fats

Feeling stressed? If so, certain fats may be lingering in your body, and presumably causing more damage. That's the word of researchers at Ohio State University who compared the blood- triglyceride levels in people who were stressed or relaxed. Triglycerides are the fats lingered longest in participants with the highest levels of stress explaining perhaps why stress is linked to Heart Disease.

  • Flu Season Comes to an End

The worst of the flu season appears to be over. That's according to the Centers for Disease Control which adds that even though it doesn't keep an actual count of flu cases, the number of patients this year appears to be less than average. So what about here at home?

No accurate reports here, either, but Tiji Ward, with the Lubbock Health Department says there were a lot of flu like illnesses this winter at sporadic times but the actual flu virus was not as bad as in previous years. But Tiji says remember hand washing is still your best prevention because there may be sporadic cases out there. This year, the health department gave over 3200 flu shots, compared to 2900 last year.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.